tiprankstipranks
Myriad Genetics (MYGN)
NASDAQ:MYGN

Myriad Genetics (MYGN) Balance Sheet

343 Followers

Myriad Genetics Balance Sheet

Myriad Genetics's total assets for Q4 2023 were $1.15B, a decrease of -0.23% from the previous quarter. MYGN total liabilities were $363.30M for the fiscal quarter, a -21.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Jun 20Jun 19
Total Assets
$ 1.15B$ 1.20B$ 1.32B$ 1.40B$ 1.56B
Total Liabilities
$ 363.30M$ 312.90M$ 352.90M$ 486.40M$ 473.80M
Total Equity Gross Minority
$ 783.20M$ 885.80M$ 967.80M$ 918.20M$ 1.09B
Total Capitalization
$ 957.60M$ 1.02B$ 967.80M$ 1.14B$ 1.32B
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 70.40M$ 0.00
Currency in USD

Myriad Genetics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis